Investment
Features
FeesSafety
Academy
More
Pluang+

AMC CEO urges Robinhood to keep voting rights for tokenized stocks abroad, matching U.S. standards.

Market News
28 Sep 2026
Tokenpost
View Source
Neutral
AMC CEO urges Robinhood to keep voting rights for tokenized stocks abroad, matching U.S. standards.

AMC Entertainment CEO Adam Aron called on Robinhood to maintain voting rights for tokenized stocks in its international markets, aligning with the company's stance in the U.S. Aron highlighted Robinhood's support for the SEC's position that tokenized U.S. stocks should have voting rights and companies can opt out. He warned against applying different rules overseas, labeling it hypocritical, and urged Robinhood not to challenge the SEC's views. Robinhood's international Stock Tokens operate on an Ethereum Layer 2 network in over 120 countries but are not available to U.S. persons.

AMC CEO Adam Aron urging Robinhood on tokenized-stock votes is the story subject, with Pluang market data providing context. For readers following cryptocurrency trends, here is Pluang's market snapshot as of Sep 28, 2026 21:27 WIB: Of 50 major cryptocurrencies, 10 rose and 39 fell today. Notable movers include ALGO (Algorand) up 14.66% at Rp2.393 with a typical hold time of 129 days, ONE (Harmony) up 13.08% at Rp45 with a 70% buy order activity, and COTI down 12.11% at Rp233 with 63% buy order activity.

More News

Vertex Pharmaceuticals rises on strong cystic fibrosis sales and promising kidney drug trials, UBS hikes price target.

Vertex Pharmaceuticals rises on strong cystic fibrosis sales and promising kidney drug trials, UBS hikes price target.

Vertex Pharmaceuticals reported a 12% revenue increase to $3.33 billion in Q2, driven by its dominant cystic fibrosis treatments. UBS raised its price target from $585 to $615, reflecting confidence in Vertex's strong financials and growth potential....

Analyst Insights
Bullish
1 hour ago
Accenture's stock jumps 37.6% on booming AI demand and strong financials ahead of Q4 earnings.

Accenture's stock jumps 37.6% on booming AI demand and strong financials ahead of Q4 earnings.

Accenture's stock surged 37.6% recently, driven by rising demand for AI services and new AI-focused offerings. The company outpaced industry growth and secured 100 new clients for advanced AI projects in one quarter. An analyst raised the price targe...

Analyst Insights
Bullish
1 hour ago
SpaceX nears Starship's first orbital launch and Starlink V3 deployment, boosting investor optimism.

SpaceX nears Starship's first orbital launch and Starlink V3 deployment, boosting investor optimism.

SpaceX, trading near $148 per share with a market cap of about $1.95 trillion, is preparing for Starship's first orbital mission and the deployment of its first operational Starlink V3 satellites. This milestone is key for expanding Starlink's global...

Market News
Bullish
2 hours ago
10x Genomics gets Buy rating despite insider selling and valuation concerns.

10x Genomics gets Buy rating despite insider selling and valuation concerns.

Argus Research initiated coverage on 10x Genomics with a Buy rating and a $110 price target, suggesting a 28% upside from its current price of around $85. The stock shows strong momentum, trading well above its 50-day and 200-day moving averages. How...

Analyst Insights
Neutral
2 hours ago
Morgan Stanley upgrades Cullen/Frost Bankers with strong institutional buying and a $201 price target.

Morgan Stanley upgrades Cullen/Frost Bankers with strong institutional buying and a $201 price target.

Morgan Stanley reaffirmed an "Overweight" rating on Cullen/Frost Bankers, Inc., raising its price target to $201, signaling confidence in the bank's prospects. Major institutional investors like State Street Corp and BlackRock have increased or initi...

Analyst Insights
Bullish
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App